Amoeba SA (PA:ALMIB) — Market Cap & Net Worth
Market Cap & Net Worth: Amoeba SA (ALMIB)
Amoeba SA (PA:ALMIB) has a market capitalization of $65.03 Million (€55.62 Million) as of May 4, 2026. Listed on the PA stock exchange, this France-based company holds position #20866 globally and #328 in its home market, demonstrating a 0.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amoeba SA's stock price €0.87 by its total outstanding shares 68885884 (68.89 Million). Analyse Amoeba SA operating cash flow efficiency to see how efficiently the company converts income to cash.
Amoeba SA Market Cap History: 2015 to 2026
Amoeba SA's market capitalization history from 2015 to 2026. Data shows change from $2.79 Billion to $70.07 Million (-27.15% CAGR).
Index Memberships
Amoeba SA is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC PME
CAPME
|
$35.32 Billion | 0.18% | #24 of 34 |
Weight: Amoeba SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Amoeba SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amoeba SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
123.29x
Amoeba SA's market cap is 123.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.79 Billion | $140.94 | -$4.02K | 19770862.62x | N/A |
| 2016 | $2.07 Billion | $125.95 | -$5.77K | 16433071.25x | N/A |
| 2017 | $1.18 Billion | $161.25 | -$6.23K | 7291836.45x | N/A |
| 2018 | $178.79 Million | $122.27 | -$7.22K | 1462233.90x | N/A |
| 2019 | $42.28 Million | $122.48K | -$7.25 Million | 345.21x | N/A |
| 2023 | $30.93 Million | $664.31K | -$14.30 Million | 46.55x | N/A |
| 2024 | $74.17 Million | $601.60K | -$6.59 Million | 123.29x | N/A |
Competitor Companies of ALMIB by Market Capitalization
Companies near Amoeba SA in the global market cap rankings as of May 4, 2026.
Key companies related to Amoeba SA by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #487 globally with a market cap of $53.89 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #742 globally with a market cap of $35.75 Billion USD ( CA$49.42 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #868 globally with a market cap of $30.42 Billion USD ( CN¥207.91 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1581 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #487 | Corteva Inc | NYSE:CTVA | $53.89 Billion | $80.85 |
| #742 | Nutrien Ltd | TO:NTR | $35.75 Billion | CA$102.24 |
| #868 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $30.42 Billion | CN¥39.29 |
| #1581 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $122.69 |
Amoeba SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Amoeba SA's market cap moved from $2.79 Billion to $ 70.07 Million, with a yearly change of -27.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €70.07 Million | -17.77% |
| 2025 | €85.21 Million | +14.88% |
| 2024 | €74.17 Million | +139.84% |
| 2023 | €30.93 Million | -54.82% |
| 2022 | €68.45 Million | -19.81% |
| 2021 | €85.37 Million | -66.03% |
| 2020 | €251.27 Million | +494.29% |
| 2019 | €42.28 Million | -76.35% |
| 2018 | €178.79 Million | -84.79% |
| 2017 | €1.18 Billion | -43.19% |
| 2016 | €2.07 Billion | -25.72% |
| 2015 | €2.79 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Amoeba SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $65.03 Million USD |
| MoneyControl | $65.03 Million USD |
| MarketWatch | $65.03 Million USD |
| marketcap.company | $65.03 Million USD |
| Reuters | $65.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more